The ClearSight System

Clearsight System

Simple, dynamic monitoring extended to a
broader patient population

Noninvasive simplicity. Next-generation clarity.
The ClearSight system expands clinician access to advanced hemodynamic parameters without the barriers of complexity or invasiveness

The ClearSight system quickly connects to the patient by wrapping an inflatable cuff around the finger.1 The simplicity of the ClearSight system gives you, noninvasive access to automatic, up-to-the-minute hemodynamic information for a broader patient population, including elderly or obese patients in whom an arterial catheter would not typically be placed.1,9,10 And enables you to make more informed decision regarding volume administration.

Noninvasive access to key hemodynamic parameters

For moderate to high-risk surgery patients who may not typically receive an arterial

EV1000 Clinical Platform Output
line, the next-generation ClearSight system offers a simple approach to monitoring key hemodynamic parameters, including:
  • Stroke Volume (SV)
  • Stroke Volume Variation (SVV)
  • Cardiac Output (CO)
  • Systemic Vascular Resistance (SVR)
  • Continuous Blood Pressure (cBP)
Valuable hemodynamic insight in moderate to high-risk surgery
Dynamic and flow-based parameters, such as SV and SVV, provided by the ClearSight system may be used in Perioperative Goal-Directed Therapy (PGDT) protocols, and are key to optimal volume administration in patients at risk of developing complications.

Visual clinical support
The EV1000 clinical platform allows clinicians to set specific color target ranges to clearly indicate patient status; and to choose parameters, alarms and targets to align with hemodynamic optimization protocols to meet your precise patient monitoring needs.

The Next Perspective on Guiding Volume Administration

The EV1000 clinical platform now offers the next perspective on guiding volume administration when used with the ClearSight system. The latest visual clinical support screens available on the EV1000 clinical platform enable you to maintain your patients in the optimal volume range and reduce volume administration variability. Time In Target facilitates Perioperative Goal-Directed Therapy (PGDT) compliance, helping the user to track and manage key parameters, and create and monitor customized protocols.

Time In Target valueThe “Time In Target” value represents the accumulated percentage of time a parameter has been within target range during an active tracking session. Clinicians have the ability to track known protocol targets in addition to identifying the optimal Stroke Volume target during active monitoring
PGDT analyticsDownloadable, off line PGDT analytics software offers additional monitoring dashboards and robust reporting features for parameter, cohort and cross-cohort analytics.

Click here for complete requirements and to download your PGDT analytics software.

Leverages validated technology
The ClearSight system leverages the ccNexfin technology which has been used as the standard for monitoring in space for decades11, ccNexfin noninvasive technology (volume clamp12, Physiocal3) has been validated against gold-standard monitoring technologies.
Clinical data demonstrate noninvasive ccNexfin BP technology obtains mean arterial pressure values comparable to invasive monitoring 3,45 with the advantage of continuous measurement.

Clearsight Noninvasive Hemodynamic Monitoring System
Several studies have shown the ability of this noninvasive technology to measure not only absolute cardiac output values, but also reliably track real-time changes in continuous cardiac output (CO).6,7,8

The ClearSight system provides valuable hemodynamic insight into an expanded patient population, for making more informed decision about volume administration in moderate to high-risk surgery.

1.  Eeftinck Schattenkerk D, et al. Nexfin Noninvasive Continuous Blood Pressure Validated Against Riva-Rocci/Korotkoff. American Journal of Hypertension 2009; 22(4):378-383.
2.  Martina JR, Westerhof BE, van Goudoever J, de Beauont EM, Truijen J, Kim YS, Immink RV, Jöbsis DA, Hollmann MW, Lahpor JR, de Mol BA, van Lieshout JJ. Noninvasive continuous arterial blood pressure monitoring with Nexfin®. Anesthesiology 2012 May;116(5):1092-103.
3.  Wesseling KH, De Wit B, Van der Hoeven GMA, van Goudoever J, Settles, JJ. Physiocal, calibrating finger vascular physiology for Finapres. Homeostasis 1995;36:67-82
4.  Kalmar AF, Vos JJ, Weening M, Mooyaart EA, Poterman M, Struys MMRF, Scheeren, TWL. Validation of Continuous Noninvasive Arterial Blood Pressure Measurements During General Anesthesia, abstract presented at the Anesthesiology Annual Meeting, 2012
5.  Sterr J, Scholz S, Habicher M, Krämer M, Treskatsch S, Sander M. Comparison of the continuous noninvasive Nexfin monitoring system with conventional invasive methods to measure arterial blood pressure in high risk hip surgery, abstract presented at Euroanesthesia, 2013
6.  Broch O, Renner J, Gruenewald M, Meybohm P, Schottler J, Caliebe A, Steinfath M, Malbrain M, Bein B. A comparison of the Nexfin® and transcardiopulmonary thermodilution to estimate cardiac output during coronary artery surgery. Anaesthesia 2012 Apr;67(4):377-83
7.  Chen G, Meng L, Alexander B, Tran NP, Kain ZN, Cannesson M. Comparison of noninvasive cardiac output measurements using the Nexfin monitoring device and the esophageal Doppler. Journal of Clinical Anesthesia (2012) Jun 1;24(4), 275-83
8.  Bubenek-Turconi SI, Craciun M, Miclea I, Perel A. Noninvasive Continuous Cardiac Output by the Nexfin Before and After Preload-Modifying Maneuvers: A Comparison with Intermittent Thermodilution Cardiac Output. Anesth Analg. 2013 Jun 11  
9.  Truijen, J et al. Noninvasive Continuous Hemodynamic Monitoring. Journal of Clinical Monitoring and Computing 2012;26(4):267-268
10.  Maguire S, et al. Respiratory Variation in Pulse Pressure and Plethysmographic Waveforms: Intraoperative Applicability in a North American Academic Center. Anesthesia & Analgesia 2011;112:94-6
11.  Hughson RL, Shoemaker JK, Blaber AP, Arbeille P, Greaves DK, Pereira-Junior PP, Xu D. Cardiovascular regulation during long-duration spaceflights to the International Space Station. J.Appl.Physiol 2012 Mar;112(5):719-27
12.  Peñáz J. Photoelectric measurement of blood pressure, volume and flow in the finger. 1973; Dresden 1973. p.104
13.  Michard F, Biais M. Rational fluid management: dissecting facts from fiction. Br J Anaesth 2012

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.